A. Vereide

发表

Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.

B. Moe, G. Sager, A. Orbo, 2009, Anticancer research.

Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.

A. Ørbo, T. Kaino, G. Sager, 2005, Gynecologic oncology.

High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.

G. Sager, A. Orbo, A. Vereide, 2009, Anticancer research.

Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".

S. Fosså, C. Tropé, H. Salvesen, 2015, Gynecologic oncology.

Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.

A. Ørbo, M. Årnes, I. Pettersen, 2008, Gynecologic oncology.

Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.

A. Ørbo, M. Årnes, T. Kaino, 2006, Gynecologic oncology.

Intrauterine Progestin Therapy as a New Approach to Premalignant Endometrial Polyps: A Prospective Observational Study

A. Ørbo, M. Årnes, A. Vereide, 2019, AntiCancer Research.

Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.

A. Ørbo, M. Årnes, A. Vereide, 2018, Anticancer research.

Effects of platelet antagonists on the reduction in platelet density caused by microbubbles in vitro.

T. Thorsen, A. Vereide, H. Holmsen, 1986, Undersea biomedical research.

Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens

A. Ørbo, M. Årnes, B. Straume, 2015, BJOG : an international journal of obstetrics and gynaecology.

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial*

A. Ørbo, M. Årnes, I. Pettersen, 2013, BJOG : an international journal of obstetrics and gynaecology.

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone.

A. Ørbo, M. Årnes, J. Maltau, 2003, Gynecologic oncology.

Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".

H. Salvesen, J. Kærn, T. Paulsen, 2015, Gynecologic oncology.